Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
3.560
+0.160 (4.71%)
Jul 7, 2025, 4:00 PM - Market closed
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $38.33 million as of July 7, 2025. Its market cap has decreased by -50.51% in one year.
Market Cap
38.33M
Enterprise Value
-24.07M
1-Year Change
-50.51%
Ranking
Category
Stock Price
$3.56
Market Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $38.33M, a decrease of -98.47%. That is a compound annual growth rate of -56.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 36.61M | -47.14% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | 2.40B | -4.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |